vs
Side-by-side financial comparison of Dine Brands Global, Inc. (DIN) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
Dine Brands Global, Inc. is the larger business by last-quarter revenue ($217.6M vs $185.2M, roughly 1.2× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -5.6%, a 6.5% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 6.3%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-8.6M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 2.7%).
Dine Brands Global Inc. is a publicly traded food and beverage company based in Pasadena, California. Founded in 1958 as IHOP, it operates franchised and corporate owned full-service restaurants including three restaurant concepts, Applebee's Neighborhood Grill & Bar, International House of Pancakes (IHOP), and Fuzzy's Taco Shop.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
DIN vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $217.6M | $185.2M |
| Net Profit | $-12.2M | $1.7M |
| Gross Margin | 42.4% | 85.7% |
| Operating Margin | -7.6% | 8.6% |
| Net Margin | -5.6% | 0.9% |
| Revenue YoY | 6.3% | 23.7% |
| Net Profit YoY | -336.1% | -88.5% |
| EPS (diluted) | $-0.79 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $217.6M | $185.2M | ||
| Q3 25 | $216.2M | $169.1M | ||
| Q2 25 | $230.8M | $154.7M | ||
| Q1 25 | $214.8M | $125.2M | ||
| Q4 24 | $204.8M | $149.7M | ||
| Q3 24 | $195.0M | $141.5M | ||
| Q2 24 | $206.3M | $126.7M | ||
| Q1 24 | $206.2M | $110.4M |
| Q4 25 | $-12.2M | $1.7M | ||
| Q3 25 | $7.3M | $17.3M | ||
| Q2 25 | $13.8M | $-24.4M | ||
| Q1 25 | $8.2M | $-21.7M | ||
| Q4 24 | $5.2M | $14.7M | ||
| Q3 24 | $19.1M | $-6.7M | ||
| Q2 24 | $23.2M | $-15.7M | ||
| Q1 24 | $17.5M | $-48.4M |
| Q4 25 | 42.4% | 85.7% | ||
| Q3 25 | 39.1% | 88.5% | ||
| Q2 25 | 40.0% | 90.2% | ||
| Q1 25 | 42.0% | 90.7% | ||
| Q4 24 | 41.7% | 90.1% | ||
| Q3 24 | 47.8% | 90.6% | ||
| Q2 24 | 48.1% | 91.1% | ||
| Q1 24 | 47.2% | 87.7% |
| Q4 25 | -7.6% | 8.6% | ||
| Q3 25 | 4.7% | 20.3% | ||
| Q2 25 | 8.2% | -6.1% | ||
| Q1 25 | 6.0% | -6.3% | ||
| Q4 24 | 3.8% | 10.7% | ||
| Q3 24 | 13.6% | 15.3% | ||
| Q2 24 | 15.1% | 11.8% | ||
| Q1 24 | 11.7% | -25.1% |
| Q4 25 | -5.6% | 0.9% | ||
| Q3 25 | 3.4% | 10.2% | ||
| Q2 25 | 6.0% | -15.8% | ||
| Q1 25 | 3.8% | -17.3% | ||
| Q4 24 | 2.5% | 9.8% | ||
| Q3 24 | 9.8% | -4.8% | ||
| Q2 24 | 11.2% | -12.4% | ||
| Q1 24 | 8.5% | -43.9% |
| Q4 25 | $-0.79 | $0.00 | ||
| Q3 25 | $0.48 | $0.06 | ||
| Q2 25 | $0.89 | $-0.08 | ||
| Q1 25 | $0.53 | $-0.07 | ||
| Q4 24 | $0.35 | $0.05 | ||
| Q3 24 | $1.24 | $-0.02 | ||
| Q2 24 | $1.50 | $-0.05 | ||
| Q1 24 | $1.13 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.2M | $293.5M |
| Total DebtLower is stronger | $1.2B | $392.7M |
| Stockholders' EquityBook value | $-273.9M | $274.2M |
| Total Assets | $1.7B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.2M | $293.5M | ||
| Q3 25 | $167.9M | $263.8M | ||
| Q2 25 | $194.2M | $231.0M | ||
| Q1 25 | $186.5M | $250.6M | ||
| Q4 24 | $186.7M | $249.9M | ||
| Q3 24 | $169.6M | $249.8M | ||
| Q2 24 | $153.5M | $260.1M | ||
| Q1 24 | $145.0M | $239.6M |
| Q4 25 | $1.2B | $392.7M | ||
| Q3 25 | $1.2B | $392.0M | ||
| Q2 25 | $1.2B | $391.3M | ||
| Q1 25 | $1.2B | $390.7M | ||
| Q4 24 | $1.2B | $390.1M | ||
| Q3 24 | $1.2B | $389.5M | ||
| Q2 24 | $1.2B | $388.9M | ||
| Q1 24 | $1.2B | $388.4M |
| Q4 25 | $-273.9M | $274.2M | ||
| Q3 25 | $-231.9M | $230.4M | ||
| Q2 25 | $-212.5M | $204.3M | ||
| Q1 25 | $-215.7M | $193.6M | ||
| Q4 24 | $-216.0M | $194.0M | ||
| Q3 24 | $-216.7M | $178.8M | ||
| Q2 24 | $-231.7M | $132.5M | ||
| Q1 24 | $-244.8M | $130.7M |
| Q4 25 | $1.7B | $949.9M | ||
| Q3 25 | $1.8B | $868.8M | ||
| Q2 25 | $1.8B | $815.3M | ||
| Q1 25 | $1.8B | $789.8M | ||
| Q4 24 | $1.8B | $785.0M | ||
| Q3 24 | $1.7B | $786.6M | ||
| Q2 24 | $1.7B | $749.5M | ||
| Q1 24 | $1.7B | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | $16.3M |
| Free Cash FlowOCF − Capex | $-8.6M | $16.0M |
| FCF MarginFCF / Revenue | -3.9% | 8.6% |
| Capex IntensityCapex / Revenue | 6.6% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $53.4M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.7M | $16.3M | ||
| Q3 25 | $30.2M | $35.7M | ||
| Q2 25 | $37.0M | $-26.5M | ||
| Q1 25 | $16.1M | $7.8M | ||
| Q4 24 | $30.5M | $-3.9M | ||
| Q3 24 | $25.5M | $-23.0M | ||
| Q2 24 | $21.6M | $22.7M | ||
| Q1 24 | $30.6M | $-29.7M |
| Q4 25 | $-8.6M | $16.0M | ||
| Q3 25 | $18.1M | $35.3M | ||
| Q2 25 | $31.0M | $-28.9M | ||
| Q1 25 | $12.8M | $7.5M | ||
| Q4 24 | $26.7M | $-4.2M | ||
| Q3 24 | $22.0M | $-23.3M | ||
| Q2 24 | $18.2M | $21.6M | ||
| Q1 24 | $27.2M | $-31.5M |
| Q4 25 | -3.9% | 8.6% | ||
| Q3 25 | 8.4% | 20.9% | ||
| Q2 25 | 13.4% | -18.7% | ||
| Q1 25 | 6.0% | 6.0% | ||
| Q4 24 | 13.0% | -2.8% | ||
| Q3 24 | 11.3% | -16.5% | ||
| Q2 24 | 8.8% | 17.0% | ||
| Q1 24 | 13.2% | -28.5% |
| Q4 25 | 6.6% | 0.2% | ||
| Q3 25 | 5.6% | 0.2% | ||
| Q2 25 | 2.6% | 1.6% | ||
| Q1 25 | 1.5% | 0.2% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 1.8% | 0.3% | ||
| Q2 24 | 1.7% | 0.9% | ||
| Q1 24 | 1.6% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 4.12× | 2.06× | ||
| Q2 25 | 2.68× | — | ||
| Q1 25 | 1.97× | — | ||
| Q4 24 | 5.88× | -0.27× | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 1.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIN
| Franchisor | $163.2M | 75% |
| Food And Beverage | $27.3M | 13% |
| Proprietary Product Sales And Other | $17.0M | 8% |
| Other | $8.1M | 4% |
| Franchise And Development Fees | $2.0M | 1% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
